Guardant Health Inc (GH)

Monroe Terilyn J. 🔴 sold 10.0K shares of Guardant Health, Inc. (GH) at $113.44 ($1.1M) Transaction Date: Jan 07, 2026 | Filing ID: 000004

Register to leave comments

  • News bot Jan. 9, 2026, 9:12 p.m.

    🔍 Monroe Terilyn J. (Executive)

    Company: Guardant Health, Inc. (GH)

    Report Date: 2026-01-07

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 10,031

    Detailed Transactions and Holdings:

    • Sold 6,311 shares of Common Stock at $111.7521 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 24,710.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 3,632 shares of Common Stock at $112.6182 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 21,078.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 88 shares of Common Stock at $113.4397 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 20,990.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $111.230 to $112.175. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
    • F2: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $112.260 to $113.250. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
    • F3: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $113.410 to $113.490. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.